14159, L.P., Director, 10% Owner at GENOMIC HEALTH INC (GHDX), bought 229,300 shares at $27.54 ($6.2M) on 2012-11-21, disclosed to the SEC on 2012-11-23.
Open-market purchase of $6.2M GHDX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.83 | 4,859 | $130K | 2.1% |
| 2 | $26.83 | 21,830 | $586K | 9.5% |
| 3 | $26.83 | 202,311 | $5.4M | 88.2% |
| 4 | $27.54 | 6 | $165 | 0.0% |
| 5 | $27.54 | 26 | $716 | 0.0% |
| 6 | $27.54 | 268 |
| $7K |
| 0.1% |
| Total | $26.83 avg | 229,300 | $6.2M | 100% |
| Filing → |
| GHDX | SELL | 2019-01-14 | $2.8M | — | Filing → |
| ACAD | BUY | 2018-12-04 | $200.0M | — | Filing → |
| GHDX | SELL | 2018-12-03 | $15.9M | — | Filing → |